Glory Vitamin C Triple-Action Glow Toner
Antipodes Glory Vitamin C Triple-Action Glow Toner: Target pigmentation and reveal bright skin with this Vitamin C toner, featuring three key glow-enhancing ingredients:
- Kakadu plum – a natural vitamin C
- Lime caviar – a natural AHA
- Melanostatine™ 5 – a tone-correcting peptide
This vegan toner is suitable for all skin types and concerns, especially those targeting pigmentation and signs of ageing. With a pure plant fragrance of fig and feijoa.
*Melanostatine™ 5 is scientifically shown to reduce pigmentation (Lucas Meyer Cosmetics).
82% say skin looks brighter after four weeks’ use (In-vivo trial results from 50 participants).
More Images
Glory Vitamin C Triple-Action Glow Toner
Antipodes Glory Vitamin C Triple-Action Glow Toner: Target pigmentation and reveal bright skin with this Vitamin C toner, featuring three key glow-enhancing ingredients:
- Kakadu plum – a natural vitamin C
- Lime caviar – a natural AHA
- Melanostatine™ 5 – a tone-correcting peptide
This vegan toner is suitable for all skin types and concerns, especially those targeting pigmentation and signs of ageing. With a pure plant fragrance of fig and feijoa.
*Melanostatine™ 5 is scientifically shown to reduce pigmentation (Lucas Meyer Cosmetics).
82% say skin looks brighter after four weeks’ use (In-vivo trial results from 50 participants).
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Antipodes Glory Vitamin C Triple-Action Glow Toner: Target pigmentation and reveal bright skin with this Vitamin C toner, featuring three key glow-enhancing ingredients:
- Kakadu plum – a natural vitamin C
- Lime caviar – a natural AHA
- Melanostatine™ 5 – a tone-correcting peptide
This vegan toner is suitable for all skin types and concerns, especially those targeting pigmentation and signs of ageing. With a pure plant fragrance of fig and feijoa.
*Melanostatine™ 5 is scientifically shown to reduce pigmentation (Lucas Meyer Cosmetics).
82% say skin looks brighter after four weeks’ use (In-vivo trial results from 50 participants).
